Interchange Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Interchange Capital Partners's LLY Position: Q2 2026 in Review
Interchange Capital Partners increased its Eli Lilly (LLY) stake by 80% in Q2 2026, buying an estimated $1.04M and bringing the position to 2,290 shares worth $2.75M. The position accounts for 0.52% of the portfolio, ranked #44.
Interchange Capital Partners first reported a position in LLY in Q4 2020 and has held it in 14 quarters since. The position peaked at $4.62M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Interchange Capital Partners held 2,290 shares of Eli Lilly worth $2.75M as of Q2 2026.
- Interchange Capital Partners bought 1,020 Eli Lilly shares in Q2 2026, an estimated $1.04M.
- Eli Lilly made up 0.52% of Interchange Capital Partners's portfolio in Q2 2026, its #44 holding.
- Interchange Capital Partners first reported a position in Eli Lilly in Q4 2020 and has held it in 14 quarters since.
- Interchange Capital Partners's Eli Lilly position peaked at $4.62M in Q4 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.